Stocks and Investing Stocks and Investing
Tue, September 24, 2024

Derek Archila Maintained (APLS) at Hold with Decreased Target to $43 on, Sep 24th, 2024


Published on 2024-10-28 14:26:13 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Decreased Target from $47 to $43 on, Sep 24th, 2024.

Derek has made no other calls on APLS in the last 4 months.



There are 10 other peers that have a rating on APLS. Out of the 10 peers that are also analyzing APLS, 3 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Graig Suvannavejh of "Mizuho" Maintained at Hold with Decreased Target to $39 on, Friday, September 20th, 2024
  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $41 on, Friday, August 9th, 2024
  • Biren Amin of "Piper Sandler" Initiated at Hold and Held Target at $46 on, Friday, May 31st, 2024


These are the ratings of the 7 analyists that currently disagree with Derek


  • Colleen Kusy of "Baird" Maintained at Buy with Decreased Target to $92 on, Monday, September 23rd, 2024
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $85 on, Friday, September 20th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $57 on, Friday, September 13th, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $74 on, Friday, August 9th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $83 on, Friday, August 9th, 2024
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $83 on, Friday, August 2nd, 2024
  • Akash Tewari of "Jefferies" Maintained at Strong Buy and Held Target at $80 on, Wednesday, July 31st, 2024
Contributing Sources